Chief People Officer · Guardant Health, Inc. (GH)

Terilyn Monroe

FY2024 is the first fiscal year CompBrief holds for Terilyn Monroe as a named executive officer of Guardant Health; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$5,519,413

Salary $439,616Stock awards $2,858,431

3rd of 7 named executive officers at Guardant Health by FY2024 total.

7 named officers on file for Guardant Health, FY2024

Terilyn Monroe’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 5 equity grants, each cited to its filing
  • GH’s disclosed peer group of 29 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Guardant Health’s whole pay program stands against its peers

  • Guardant Health’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GH→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Terilyn Monroe’s full pay file as a PDF — free

More than this page: up to 10 years of Terilyn’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Terilyn Monroe compensation by year

Guardant Health Summary Compensation Table · the one fiscal year held
In US dollars, as Guardant Health reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$439,616
Bonus$0
Stock awards$2,858,431
Option awards$1,873,441
Non-equity incentive$337,500
Pension and deferred compensation$0
All other$10,425
Total$5,519,413

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Guardant Health, Inc. DEF 14A filed April 29, 2025, accession 0001193125-25-103890, and prior-year filings.

How this page was built: the Guardant Health, Inc. filed document, accession 0001193125-25-103890. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU52,136$1,592,755—
PSU44,688$1,365,218—
RSU31,751$969,993—
PSU22,344$682,609—
Option78,204—$20.14
Option47,627—$28.61

Per the Outstanding Equity Awards at Fiscal Year-End table in Guardant Health, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

59 Form 4 lines since the FY2024 proxy (filed April 29, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-11-18Sale10b5-1100$144.5821,058
2026-11-18Sale10b5-1500$140.6424,400
2026-11-18Sale10b5-11,338$142.8321,862
2026-11-18Sale10b5-1704$143.6421,158
2026-11-18Sale10b5-11,200$141.7923,200
2026-10-01Exercise or conversion derivative—1,360$0.008,162
2026-10-01Exercise or conversion—2,659$0.0025,638
2026-10-01Exercise or conversion—1,360$0.0026,998

The 8 most recent of 59 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments Guardant Health discloses, by trigger · FY2024
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary termination without cause$675,000$0$33,784$708,784
Change in control and involuntary termination$900,000$5,517,075$50,676$6,467,752
Death$0$0$0$0
Change in control, no termination$0$0$0$0
Disability$0$0$0$0

Per the Potential Payments Upon Termination or Change in Control table in Guardant Health, Inc.'s FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.

Guardant Health’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
AmirAli TalasazCo-Chief Executive Officer$11,613,545
Helmy EltoukhyChairman and Co-Chief Executive Officer$11,613,450
Terilyn Monroe · this pageChief People Officer$5,519,413
Michael BellChief Financial Officer$3,606,871
Darya ChudovaChief Technology Officer$3,475,523
John SaiaChief Legal Officer$3,203,146
Craig EagleChief Medical Officer$3,111,407

The full Guardant Health compensation record

free company brief

This page is one person within Guardant Health's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Guardant Health proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Guardant Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Terilyn Monroe's compensation dossier · One-time report. No refunds.